Herpesvirus prevalence and viral load in healthy blood donors by quantitative real‐time polymerase chain reaction
- 15 April 2008
- journal article
- Published by Wiley in Transfusion
- Vol. 48 (6) , 1180-1187
- https://doi.org/10.1111/j.1537-2995.2008.01685.x
Abstract
BACKGROUND: After primary infection, human herpesviruses (HHVs) maintain long‐term latent persistence, often punctuated years later by sporadic episodes of symptomatic lytic activation. Also, blood‐borne herpesvirus from healthy persistently infected blood donors can lead to active primary infection of immunocompromised transfusion recipients. STUDY DESIGN AND METHODS: Utilizing a set of newly developed real‐time polymerase chain reaction assays for detection and quantification of all eight human herpesviruses, the prevalence and viral DNA load of white cell–enriched blood from 100 randomly selected blood donors from the southeast Texas region are reported. RESULTS: Herpes simplex viruses 1 and 2 (HSV‐1 and HSV‐2), varicella‐zoster virus (VZV), and HHV‐8 DNA were not detected in any donor sample. In contrast, Epstein‐Barr virus (EBV) (72%) and HHV‐7 (65%) were commonly detected, HHV‐6 (30%) was often detected (Type B only), and cytomegalovirus (CMV; 1%) was rarely detected. Median viral loads of positive samples (per milliliter of blood) ranged from 4278 for HHV‐6 to less than 46 for EBV. CONCLUSIONS: These results suggest that the potential for transfusion‐mediated transmission of herpesviruses from healthy adult blood donors is high for EBV and HHV‐7; moderately high for HHV‐6; uncommon for CMV; and rare for HSV‐1, HSV‐2, VZV, and HHV‐8. Perhaps the most remarkable finding in this study was the detection of a single donor sample with greater than 6.1 × 107 HHV‐6 Type B genome equivalents per mL blood. Given that this extraordinarily high level of HHV‐6 DNA was obtained from a healthy adult blood donor, this phenomenon is likely unrelated to active infection or immunodeficiency.Keywords
This publication has 38 references indexed in Scilit:
- Analytic Validation of a Quantitative Real-time PCR Assay to Measure CMV Viral Load in Whole BloodDiagnostic Molecular Pathology, 2007
- Epidemiology of Epstein–Barr virus, cytomegalovirus, and kaposi's sarcoma-associated herpesvirus infections in peripheral blood leukocytes revealed by a multiplex PCR assayJournal of Medical Virology, 2006
- Human Herpesvirus InfectionsPublished by Elsevier ,2006
- Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reactionAnnals of the Rheumatic Diseases, 2005
- Efficacy of Epstein‐Barr virus removal by leukoreduction of red blood cellsTransfusion, 2005
- Molecular Parameters for Precise Diagnosis of Asymptomatic Epstein-Barr Virus Reactivation in Healthy CarriersJournal of Clinical Microbiology, 2003
- Persistent epstein-barr virus infection: unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients1Transplantation, 2002
- Multicenter evaluation of PCR methods fordetecting CMV DNA in blood donorsTransfusion, 2001
- Normalized Quantification by Real-Time PCR of Epstein-Barr Virus Load in Patients at Risk for Posttransplant Lymphoproliferative DisordersJournal of Clinical Microbiology, 2001
- Detection of herpesviruses by polymerase chain reaction in lymphocytes from patients with rheumatoid arthritisArthritis & Rheumatism, 1993